| レジメン名 | レジメンNo |
|---|---|
| 3wTrastuzumab | 05010 |
| 3wTrastuzumab+wPAC | 05033 |
| Atezolizumab+nabPAC | 05035 |
| ddEC→ddPAC | 05032 |
| DOC | 05004 |
| DOC+Trastuzumab(進行・再発) | 05027 |
| DOC+Trastuzumab→Trastuzumab(周術期) | 05030 |
| EC | 05002 |
| Eriburin | 05018 |
| GEM | 05015 |
| Pertuzumab+Trastuzumab | 05023 |
| Pertuzumab+Trastuzumab+DOC | 05025 |
| Pertuzumab+Trastuzumab+wPAC | 05022 |
| Pembrolizumab | 99001 |
| TC | 05011 |
| Trastuzumab Emtansine | 05028 |
| VNR | 05005 |
| wTrastuzumab | 05007 |
| wPAC | 05003 |
| Pembrolizumab+GEM+CBDCA | 05039 |
| Pembrolizumab+PAC | 05040 |
| Pembrolizumab+nabPAC | 05041 |
| Pembrolizumab+[CBDCA+PAC→EC] | 05042 |
| Trastuzumab Deruxtecan | 05037 |
| Pembrolizumab(6週毎) | 99002 |
| PHESGO | 05045 |
| Sacituzumab GovitecanO | 05046 |
医療関係者の方